Hormones: all 321 studies that test it

Page 2 of 4. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Acthar in Treatment of Refractory Dermatomyositis and PolymyositisCompletedNCT01906372Phase 2Results posted
• Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesCompletedNCT01794793Phase 4Results posted
• Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation CyclesCompletedNCT01785095Phase 3Results posted
• Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)CompletedNCT01764711Not applicableResults posted
• Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active DiseaseCompletedNCT01753401Phase 4Results posted
• Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary GigantismCompletedNCT01673646Phase 2Results posted
• Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 2Results posted
• Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01639352Phase 2Results posted
• Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping SyndromeCompletedNCT01637272Phase 2Results posted
• Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant ProlactinomasCompletedNCT01620138Phase 2/3Results posted
• Acthar for Treatment of Proteinuria in Diabetic Nephropathy PatientsCompletedNCT01601236Phase 2Results posted
• 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA TrialCompletedNCT01563354Phase 2Results posted
• Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaCompletedNCT01556594Phase 2Results posted
• Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01488487Phase 2Results posted
• Physiologic Response to Glucagon at Varying Insulin LevelsCompletedNCT01483651Not applicableResults posted
• Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01468532Phase 1/2Results posted
• Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyTerminatedNCT01410799Phase 2Results posted
• Acthar for Treatment of Proteinuria in Membranous Nephropathy PatientsCompletedNCT01386554Phase 4Results posted
• Breast Cancer Chemoprevention by SOM230, an IGF-I Action InhibitorTerminatedNCT01372618Phase 1/2Results posted
• Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.CompletedNCT01283542Phase 2Results posted
• Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid CancerCompletedNCT01270321Phase 2Results posted
• Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTHCompletedNCT01155141Phase 4Results posted
• Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled AcromegalyCompletedNCT01137682Phase 3Results posted
• Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)CompletedNCT01129284Phase 4Results posted
• Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male VolunteersCompletedNCT01128192Phase 2Results posted
• The Adrenal Contribution to Androgen Production in Girls During PubertyCompletedNCT01062568Phase 3Results posted
• Assessment of Multiple Intrauterine Gestations From Ovarian StimulationCompletedNCT01044862Phase 3Results posted
• Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and AbscessCompletedNCT00994110Phase 3Results posted
• Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary SyndromeCompletedNCT00989781Not applicableResults posted
• Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal BleedingCompletedNCT00966355Phase 4Results posted
• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginTerminatedNCT00958841Phase 2Results posted
• Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph AdenomasTerminatedNCT00929669Phase 2Results posted
• Effect of Short Term Growth Hormone Releasing Hormone in Healthy MenCompletedNCT00850564Not applicableResults posted
• Phase II Study of SOM230 in Patients With Recurrent or Progressive MeningiomaTerminatedNCT00813592Phase 2Results posted
• Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyTerminatedNCT00807365Phase 2Results posted
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin AloneCompletedNCT00797823Phase 2Results posted
• Effects of Short-term Growth Hormone in HIV-infected PatientsCompletedNCT00795210Not applicableResults posted
• The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic PatientsTerminatedNCT00791076Phase 2Results posted
• Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related FatigueTerminatedNCT00790296Phase 2Results posted
• Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 TeslaCompletedNCT00786825Phase 2Results posted
• Adult Growth Hormone Deficiency and Cardiovascular RiskTerminatedNCT00720902Phase 4Results posted
• Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid DiseaseCompletedNCT00690430Phase 3Results posted
• Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active AcromegalyCompletedNCT00600886Phase 3Results posted
• Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's DiseaseCompletedNCT00434148Phase 3Results posted
• Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.CompletedNCT00335725Phase 3Results posted
• Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's DiseaseCompletedNCT00171951Phase 2Results posted
• An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With AcromegalyCompletedNCT00171730Phase 2Results posted
• Study Evaluating SOM230 in Patients With Metastatic Carcinoid TumorsCompletedNCT00088595Phase 2Results posted
• Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary AbnormalitiesCompletedNCT00054756Phase 2Results posted
• Feasibility Study for Development of an Early Test for Ovarian FailureCompletedNCT00006156Not applicableResults posted
• Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PETActive, not recruitingNCT07366710Not applicable
• 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE TrialWithdrawnNCT07346235Phase 3
• Glucagon Dose-Response in Patients With Post-Bariatric HypoglycemiaActive, not recruitingNCT06986603Phase 4
• Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1TerminatedNCT05960565Phase 2
• Pasireotide s.c. in Patients With Post-Bariatric HypoglycaemiaActive, not recruitingNCT05928390Phase 2
• Pancreatic Clamp in NAFLDCompletedNCT05724134Phase 1
• Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic AxesCompletedNCT05206149Phase 4
• Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 DiabetesCompletedNCT05076292Not applicable
• The Role of the Kidneys and Liver in the Elimination of GlucagonCompletedNCT05056584Not applicable
• Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 DiabetesCompletedNCT04949867Phase 4
• Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid CancerWithdrawnNCT04868045Phase 1
• The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid TurnoverCompletedNCT04859322Not applicable
• Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal CarcinomatosisTerminatedNCT04826432Phase 2
• Treatment of Refractory Gout With ACTH or MethylprednisoloneStatus unknownNCT04808856Not applicable
• A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 DiabetesCompletedNCT04712266Early Phase 1
• The Role of Secretin on the Energy HomeostasisCompletedNCT04613700Not applicable
• Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)CompletedNCT04461535Not applicable
• Effects of FSH on Endothelial Function (FEND)Status unknownNCT04430621Phase 4
• FSH Followed by HMG vs FSH Plus HMG in IVFStatus unknownNCT04385342Phase 4
• Glucagon Regulation of Glucose MetabolismCompletedNCT04347252Phase 1
• ACTH vs Betamethasone in Hospitalized Patients With Acute GoutStatus unknownNCT04306653Not applicable
• Effect of Physiologic Hyperglucogonemia on Adipocyte MetabolismCompletedNCT04300049Early Phase 1
• Somatostatin in Living Donor Liver TransplantationStatus unknownNCT04107428Phase 4
• Dual-hormone Closed-loop Glucose Control in Type 1 DiabetesCompletedNCT04053712Phase 4
• Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal WomenActive, not recruitingNCT04037605Early Phase 1
• The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver ResectionStatus unknownNCT04010669Phase 3
• Direct Measurement of Proinsulin Clearance in HumansWithdrawnNCT03998293Phase 4
• Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During RamadanCompletedNCT03970772Not applicable
• A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310CompletedNCT03847207Phase 1
• Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male VolunteersCompletedNCT03835013Not applicable
• Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric SurgeryCompletedNCT03770637Phase 2
• Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal VolunteersWithdrawnNCT03752190Phase 4
• Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)CompletedNCT03727776Early Phase 1
• Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children StudyCompletedNCT03709381Early Phase 1
• Secretin for Acute PancreatitisStatus unknownNCT03686618Phase 2
• Intranasal Glucagon and Energy BalanceStatus unknownNCT03650582Phase 2/3
• Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced CardioinhibitionCompletedNCT03533179Phase 4
• Hepatic Metabolic Changes in Response to Glucagon InfusionCompletedNCT03526445Not applicable
• Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass SurgeryStatus unknownNCT03514576Phase 4
• The Effects of Acthar on Synovial Inflammation in Rheumatoid ArthritisActive, not recruitingNCT03511625Phase 3
• Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)CompletedNCT03419650Phase 4
• ACTHAR Gel for Drug REsistant Nephrotic Syndrome in ChildrenWithdrawnNCT03408405Phase 4
• Repository Corticotropin Injection in Keratoconjunctivitis SiccaWithdrawnNCT03398018Phase 4
• Step Down FSH Approach and Late Follicular Phase in Progesterone LevelCompletedNCT03356964Early Phase 1
• Somatostatin Prevent Post-operation Pancreatic Fistula in Intermediate Risk Patients After PancreaticoduodenectomyCompletedNCT03349424Phase 4
• A Novel Approach to Infantile SpasmsSuspendedNCT03347526Phase 3
• Hormonal Mechanisms of Sleep Restriction - Axis StudyActive, not recruitingNCT03142893Phase 1
• Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese SubjectsActive, not recruitingNCT03139305Phase 1
• Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic HypoglycemiaCompletedNCT03103009Phase 1
• Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar GelStatus unknownNCT03082573Phase 4

← Hormones overview